Serra Kamer

Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy? CHILDS NERVOUS SYSTEM, vol.34, pp.1657-1662, 2018 (Link)

Burcu Akıncı, Nazan Çetingül, Hamiyet Hekimci Özdemir et al. · RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS)) · 2018 · 95 citations · Full text

Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study

Yavuz Anacak, Robert C. Miller, Nikos Constantinou et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 67 citations · Full text

Lymphoid Neoplasia, Surgical Pathology, Pathology +5

Palliative treatment of Erdheim–Chester disease with radiotherapy: A Rare Cancer Network study

Robert C. Miller, S. Villà, Serra Kamer et al. · Radiotherapy and Oncology · 2006 · 43 citations

Radiation Medicine, Palliative Treatment, Radiation Therapy +8

Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience

Banu Atalar, Mahmut Özsahin, Jason A. Call et al. · Radiotherapy and Oncology · 2018 · 35 citations

Prognostic Factors, Neuro-oncology, Rare Cancer Network +7

Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341)

Serra Kamer, Qing Ren, Adam P. Dicker · Archives of Gynecology and Obstetrics · 2008 · 26 citations

Cervical Cancer, Radiation Therapy, Medicine +7